{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:17:59Z","timestamp":1791505079325,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1124\/jpet.110.167148","type":"journal-article","created":{"date-parts":[[2010,3,31]],"date-time":"2010-03-31T01:37:35Z","timestamp":1269999455000},"page":"232-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Pharmacodynamic and Pharmacokinetic Characterization of the Aldosterone Synthase Inhibitor FAD286 in Two Rodent Models of Hyperaldosteronism: Comparison with the 11\u03b2-Hydroxylase Inhibitor Metyrapone"],"prefix":"10.1016","volume":"334","author":[{"given":"Dean F.","family":"Rigel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chii-Whei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arco Y.","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.167148_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.vascn.2008.01.002","article-title":"Development of a simplified assay for determination of the antimineralocorticoid activity of compounds dosed in rats","volume":"57","author":"Brandish","year":"2008","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.110.167148_bib2","first-page":"703","article-title":"Sites of metyrapone inhibition of steroid biosynthesis by rat adrenal mitochondria","volume":"76","author":"Carballeira","year":"1974","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1124\/jpet.110.167148_bib3","doi-asserted-by":"crossref","first-page":"4F","DOI":"10.1016\/j.amjcard.2006.03.004","article-title":"Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology","volume":"97","author":"Cohn","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.110.167148_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.06017","article-title":"The new biology of aldosterone","volume":"186","author":"Connell","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1124\/jpet.110.167148_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2265.1990.tb00906.x","article-title":"Potency and selectivity of the nonsteroidal aromatase inhibitor CGS16949A in postmenopausal breast-cancer patients","volume":"32","author":"Dowsett","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1124\/jpet.110.167148_bib6","first-page":"134","article-title":"Aldosterone, mineralocorticoid receptors, and vascular inflammation","volume":"16","author":"Fiebeler","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1124\/jpet.110.167148_bib7","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1161\/CIRCULATIONAHA.104.521625","article-title":"Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage","volume":"111","author":"Fiebeler","year":"2005","journal-title":"Circulation"},{"key":"10.1124\/jpet.110.167148_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2217\/14796678.2.5.535","article-title":"Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockade","volume":"2","author":"Funder","year":"2006","journal-title":"Future Cardiol"},{"key":"10.1124\/jpet.110.167148_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","article-title":"Reconsidering the roles of the mineralocorticoid receptor","volume":"53","author":"Funder","year":"2009","journal-title":"Hypertension"},{"key":"10.1124\/jpet.110.167148_bib10","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","article-title":"Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice","volume":"110","author":"Garnier","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/jpet.110.167148_bib11","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1210\/endo.138.8.5326","article-title":"Aldosterone biosynthesis in the rat brain","volume":"138","author":"Gomez-Sanchez","year":"1997","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.167148_bib12","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/jpet.110.167148_bib13","first-page":"680","article-title":"Effects of prolonged infusions of potassium chloride, adrenocorticotrophin or angiotensin II upon serum aldosterone concentration and the conversion of corticosterone to aldosterone in rats","volume":"90","author":"Komor","year":"1979","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1124\/jpet.110.167148_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ab.2009.07.025","article-title":"Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors","volume":"394","author":"LaSala","year":"2009","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.110.167148_bib15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ki.2009.9","article-title":"Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt","volume":"75","author":"Lea","year":"2009","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.110.167148_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/HYPERTENSIONAHA.107.098897","article-title":"Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase","volume":"51","author":"Makhanova","year":"2008","journal-title":"Hypertension"},{"key":"10.1124\/jpet.110.167148_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clin Sci"},{"key":"10.1124\/jpet.110.167148_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0022-4731(89)90461-5","article-title":"Effects of the infusion with ACTH or CRH on the secretory activity of rat adrenal cortex","volume":"32","author":"Mazzocchi","year":"1989","journal-title":"J Steroid Biochem"},{"key":"10.1124\/jpet.110.167148_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ncpendmet0676","article-title":"Drug insight: eplerenone, a mineralocorticoid-receptor antagonist","volume":"4","author":"McManus","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1124\/jpet.110.167148_bib20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/01.hjh.0000226205.65442.f2","article-title":"Investigation of aldosterone-synthase inhibition in rats","volume":"24","author":"M\u00e9nard","year":"2006","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.110.167148_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/01.hjh.0000226183.98439.b3","article-title":"Can the dextroenantiomer of the aromatase inhibitor fadrozole be useful for clinical investigation of aldosterone-synthase inhibition?","volume":"24","author":"M\u00e9nard","year":"2006","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.110.167148_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1210\/en.2007-0584","article-title":"Fadrozole reverses cardiac fibrosis in spontaneously hypertensive heart failure rats: discordant enantioselectivity versus reduction of plasma aldosterone","volume":"149","author":"Minnaard-Huiban","year":"2008","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.167148_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1210\/endo-96-1-178","article-title":"The metabolism and binding properties of 3H-aldosterone in plasma and its sex dependence in adrenalectomized rats","volume":"96","author":"Morris","year":"1975","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.167148_bib24","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/eurheartj\/ehn277","article-title":"Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone","volume":"29","author":"Mulder","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.110.167148_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jsbmb.2005.04.032","article-title":"The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11B2 (aldosterone synthase) and CYB11B1 (steroid-11 \u03b2-hydroxylase) inhibitors","volume":"96","author":"M\u00fcller-Vieira","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/jpet.110.167148_bib26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1248\/bpb.20.188","article-title":"Stereoselective reductive metabolism of metyrapone and inhibitory activity of metyrapone metabolites, metyrapol enantiomers, on steroid 11 \u03b2-hydroxylase in the rat","volume":"20","author":"Nagamine","year":"1997","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/jpet.110.167148_bib27","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2004.033159","article-title":"Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays","volume":"50","author":"Perschel","year":"2004","journal-title":"Clin Chem"},{"key":"10.1124\/jpet.110.167148_bib28","doi-asserted-by":"crossref","unstructured":"Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, Berman AA, Linehan WM, Doppman JL, Gill JR Jr Jr (2000) Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 85:4526\u20134533.","DOI":"10.1210\/jcem.85.12.7086"},{"key":"10.1124\/jpet.110.167148_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.110.167148_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2002.tb04415.x","article-title":"The pathophysiology of aldosterone in the cardiovascular system","volume":"970","author":"Rocha","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/jpet.110.167148_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3317\/jraas.2000.008","article-title":"Rat model for investigating ACTH-independent angiotensin-induced aldosterone secretion","volume":"1","author":"Roesch","year":"2000","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1124\/jpet.110.167148_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10822-007-9128-9","article-title":"Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics","volume":"21","author":"Roumen","year":"2007","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/jpet.110.167148_bib33","first-page":"R1453","article-title":"Roles of aldosterone and angiotensin in maturation of sodium appetite in furosemide-treated rats","volume":"276","author":"Rowland","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.110.167148_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mce.2003.10.047","article-title":"Aldosterone target organ protection by eplerenone","volume":"217","author":"Rudolph","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.110.167148_bib35","first-page":"807","article-title":"The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27","volume":"131","author":"Sander","year":"1992","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.167148_bib36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1113\/expphysiol.2008.042085","article-title":"Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats","volume":"93","author":"Siragy","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1124\/jpet.110.167148_bib37","first-page":"1381","article-title":"Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A","volume":"50","author":"Stein","year":"1990","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.110.167148_bib38","first-page":"571","article-title":"The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects","volume":"74","author":"Trunet","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.110.167148_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/eje.0.1500517","article-title":"Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass","volume":"150","author":"Unger","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1124\/jpet.110.167148_bib40","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.110.167148_bib41","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/en.2003-0109","article-title":"Regulation of aldosterone synthase gene expression in the rat adrenal gland and central nervous system by sodium and angiotensin II","volume":"144","author":"Ye","year":"2003","journal-title":"Endocrinology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652445893X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652445893X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.167148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:14:53Z","timestamp":1740017693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652445893X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S002235652445893X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.167148","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic and Pharmacokinetic Characterization of the Aldosterone Synthase Inhibitor FAD286 in Two Rodent Models of Hyperaldosteronism: Comparison with the 11\u03b2-Hydroxylase Inhibitor Metyrapone","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.167148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}